www.bloomberg.com
Shionogi & Co. will invest $2.1 billion to increase its stake in ViiV Healthcare to 21.7%. This transaction, acquiring a portion of Pfizer’s stake, reinforces Shionogi’s commitment to focusing on HIV and other major infectious diseases. The move strengthens the Japanese drugmaker’s presence in the global HIV market.
Read More
